UC Davis Institute for Psychedelics and Neurotherapeutics

A recent study published in #Neuropharmacology with long-time IPN collaborator Jamie Peters, PhD, MBA explores how the psychedelic drug DOI can reduce motivation for heroin in a model involving both heroin and alcohol use. The study found that DOI, acting on 5-HT2A receptors, selectively decreases heroin motivation without affecting alcohol use. This research adds to the growing body of evidence supporting #psychedelics as promising treatments for substance use disorders! ?#SubstanceUseDisorder #OpioidCrisis?

The FDA has just approved a drug with a new mechanism of action for the treatment of schizophrenia, opening the door to novel approaches in mental health care. As we continue our work at the Institute for Psychedelics and Neurotherapeutics, it’s incredible to see advancements that reshape the way we treat complex neurological conditions. These breakthroughs remind us of the power of innovation in healing the brain and improving lives. #Schizophrenia #MentalHealth #Neuroscience?

Stay up-to-date with the latest news and media coverage of the IPN! ??? Click the link below to learn more about our work, and sign up for our newsletter to never miss an update! ?? #Psychedelics #Neurotherapeutics #UCDavis

A hardy?congratulations?to two of our faculty affiliates, Theanne Griffith and George (Ron) Mangun for being honored by the Society for Neuroscience. Dr. Griffith's impactful work in neuroscience education continues to inspire the next generation of scientists, while Dr. Mangun's dedication to advancing neuroscience through both research and outreach has made a lasting impact on the field. Read more about the awards at the link below. UC Davis Center for Mind and Brain #Neuroscience #UCDavis #SfN24

Dive into the fascinating world of #neuroplasticity and #psychedelics with our Associate Director John A. Gray, MD PhD on the Audible River Podcast! Explore how psychedelics are unlocking new potential in #neuroscience and #mentalhealth treatment. Listen here or wherever you get your podcasts:

The Biden administration has finalized new regulations to ensure that health insurers cover mental health care as comprehensively as physical health conditions. The rule aims to close loopholes and prevent insurers from using more restrictive processes for mental health. Everyone should have access to proper care. We should be treating mental health conditions as readily as we treat broken bones! #MentalHealthParity #HealthcareReform #MentalHealthAccess Read more:

Don't forget to register for Cure Addiction Now's free public forum and webinar! The virtual forum begins tomorrow, September 7th. Sign up now at the link below. #CAN #SUD #CureAddictionNow

Our paper on psychedelic-induced neuroplasticity has now been cited 1,000 times! This work set the stage for our institute's mission and?continues to shape the future of #psychedelic research and therapeutic #innovation.?Here's to many more breakthroughs and the continued impact of this pioneering work! Congratulations to coauthors David E. Olson, Megan Dennis, Kimberley McAllister, Kassandra Ori-McKenney, and John A. Gray, MD PhD. You can read the paper?that started it all at the link below. https://lnkd.in/dMEYr_e #ucdavis UC Davis College of Letters and Science University of California, Davis - School of Medicine UC Davis Center for Neuroscience

Register for Cure Addiction Now's free public forum and webinar! CAN is a nonprofit organization dedicated to finding treatments for addiction, and this forum is an excellent opportunity for the public to interact with the scientists working in this area. Register for the virtual forum happening on September 7th. #CAN #SUD #CureAddictionNow

Great opportunity at the IPN if you are interested in CNS drug discovery!